India saw a single day rise of 4,184 coronavirus infections taking the total tally of COVID-19 cases to 4,29,80,067, while the active cases dipped to 44,488, according to the Union Health Ministry data updated on Thursday.
The death toll climbed to 5,21,736 with 26 fresh fatalities, the data updated at 8 am stated.
A total of 3,00,41,400 samples have been tested until August 16 with 7,31,697 samples being tested on Sunday, the Indian Council of Medical Research said.
In Jaipur, the combination of lopinavir and ritonavir, both second-line HIV drugs, was administered was administered on an elderly Italian couple undergoing treatment for Covid-19 at the SMS Hospital.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
The COVID-19 case fatality rate has further declined to 1.52 per cent.
India on Saturday recorded 89,129 new COVID-19 cases in a day, the highest daily rise in around six-and-half-months, taking the nationwide tally of infections to over 1.23 crore, according to the Union Health Ministry data on Saturday.
India logged 14,148 new coronavirus infections, taking the total tally of COVID-19 cases to 4,28,81,179, while the active cases dipped to 1,48,359, according to the Union health ministry data.
The Indian students who arrived in the city of Bucharest in Romania from Ukraine said that the national tricolour helped them as well as some Pakistani and Turkish students in safely crossing the various checkpoints in the war-torn country.
Nearly half of all coronavirus patients in the country have been cured, taking the recovery rate to over 48 per cent.
'I don't think the Bharatiya Janata Party can claim any USP which was it is a party with a difference.'
There are 7,85,996 active cases of coronavirus infection in the country which comprises 21.29 per cent of the total caseload, the data stated.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances